These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4003313)

  • 1. Flecainide-induced aggravation of ventricular arrhythmias.
    Wehr M; Noll B; Krappe J
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1643-4. PubMed ID: 4003313
    [No Abstract]   [Full Text] [Related]  

  • 2. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.
    Nathan AW; Hellestrand KJ; Bexton RS; Banim SO; Spurrell RA; Camm AJ
    Am Heart J; 1984 Feb; 107(2):222-8. PubMed ID: 6695656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sinusoidal ventricular tachycardia associated with flecainide acetate.
    Sellers TD; DiMarco JP
    Chest; 1984 May; 85(5):647-9. PubMed ID: 6201323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular tachycardia associated with flecainide.
    Muhiddin K; Nathan AW; Hellestrand KJ; Banim SO; Camm AJ
    Lancet; 1982 Nov; 2(8309):1220-1. PubMed ID: 6128526
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flecainide versus quinidine: results of a multicenter trial.
    Hodges M; Salerno DM; Granrud G
    Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced ventricular tachycardia as a manifestation of flecainide toxicity.
    Hoffmann A; Wenk M; Follath F
    Int J Cardiol; 1986 Jun; 11(3):353-5. PubMed ID: 3721634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flecainide: a new agent for the treatment of ventricular arrhythmias.
    Grubb BP; Tilley-Gray B
    Am J Med Sci; 1986 Sep; 292(3):160-3. PubMed ID: 3529958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.
    Duff HJ; Roden DM; Maffucci RJ; Vesper BS; Conard GJ; Higgins SB; Oates JA; Smith RF; Woosley RL
    Am J Cardiol; 1981 Dec; 48(6):1133-40. PubMed ID: 7304461
    [No Abstract]   [Full Text] [Related]  

  • 10. Refractory ventricular tachycardia with flecainide.
    Wynn J; Fingerhood M; Keefe D; Maza S; Miura D; Somberg JC
    Am Heart J; 1986 Jul; 112(1):174-5. PubMed ID: 3728275
    [No Abstract]   [Full Text] [Related]  

  • 11. Flecainide-induced aggravation of ventricular tachycardia.
    Hohnloser S; Zeiher A; Hust MH; Wollschläger H; Just H
    Clin Cardiol; 1983 Mar; 6(3):130-5. PubMed ID: 6851274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proarrhythmic effects of flecainide.
    Nathan AW; Hellestrand KJ; Bexton RS; Spurrell RA; Camm AJ
    Drugs; 1985; 29 Suppl 4():45-53. PubMed ID: 4006779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proposal for the clinical use of flecainide.
    Anderson JL; Stewart JR; Crevey BJ
    Am J Cardiol; 1984 Feb; 53(5):112B-119B. PubMed ID: 6364767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of intravenous flecainide in the treatment of acute ventricular arrhythmia].
    Aliot E; Baille N; Zannad F; Gilgenkrantz JM
    Ann Cardiol Angeiol (Paris); 1983 Oct; 32(6):417-23. PubMed ID: 6666988
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of flecainide with quinidine for suppression of chronic stable ventricular ectopic depolarizations. A double-blind randomized study in ambulatory outpatients.
    Salerno DM; Hodges M; Granrud G; Sharkey P
    Ann Intern Med; 1983 Apr; 98(4):455-60. PubMed ID: 6340575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy. Flecainide.
    Roden DM; Woosley RL
    N Engl J Med; 1986 Jul; 315(1):36-41. PubMed ID: 3520324
    [No Abstract]   [Full Text] [Related]  

  • 17. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flecainide: a new class Ic antidysrhythmic.
    Smith GH
    Drug Intell Clin Pharm; 1985 Oct; 19(10):703-7. PubMed ID: 3902429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with electrophysiologically guided therapy of ventricular tachycardia with flecainide: summary of long-term follow-up.
    Anderson JL
    Am J Cardiol; 1984 Feb; 53(5):79B-86B. PubMed ID: 6695820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flecainide: a new antiarrhythmic drug.
    Med Lett Drugs Ther; 1986 Feb; 28(707):19-20. PubMed ID: 3951388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.